| MSD Merck Sharp & Dohme AG - Welireg 40 mg, Filmtabletten | | 68531 | | 01 | | Welireg 40 mg | | Filmtabletten | | | | | | 21.03.2024 | | |
| | Composition | | belzutifanum 40 mg, hypromellosi acetas succinas, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, pro compresso obducto corresp. natrium 1.356 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Belzutifanum | 40 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Hypromellosi Acetas Succinas | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Mannitol | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 90 | PR | PR | A | | No |
|
|
